tm
Seeing Is Believing
tm
Seeing Is Believing
Jounce Therapeutics's activity chart (see below) currently has 28 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25.93% with an average time for these price targets to be met of 213.22 days.
Most recent stock forecast was given by from BAIRD on 28-Mar-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Mar-2023
$2
$0.12 (6.38%)
3 years 6 months 9 days ago
(28-Mar-2023)
0/2 (0%)
$0.16 (8.70%)
Buy Since 16-Mar-2022
$17
3 years 7 months 13 days ago
(24-Feb-2023)
0/1 (0%)
$9.68 (132.24%)
Buy Since 18-Sep-2021
3 years 7 months 14 days ago
(23-Feb-2023)
2/8 (25%)
$1.83 (156.41%)
622
Buy Since 23-May-2022
$5
$3.12 (165.96%)
3 years 9 months 4 days ago
(03-Jan-2023)
0/2 (0%)
$3.91 (358.72%)
Buy Since 26-Feb-2021
$11
$9.12 (485.11%)
$15
4 years 2 months 2 days ago
(05-Aug-2022)
0/2 (0%)
$6.84 (164.42%)
What is JNCE (Jounce Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on JNCE (Jounce Therapeutics)?
Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?
Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?
Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?
